1194565

Xellia Pharmaceuticals USA LLC — FEI 3012279857

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 15, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bedford, OH (United States)